Benchmark Animal Health, the aquaculture biotechnology company, has entered an exclusive distribution agreement with STIM Scotland Ltd for Salmosan®Vet in the UK. The agreement was signed on 28 March 2023, and will take immediate effect with the stock now transferred to STIM’s Glasgow warehouse ahead of distribution.
%20and%20Harry%20Tziouvas%20(Global%20Sales%20Manager,%20Salmon).jpg)
Salmosan® Vet is a market leading azamethiphos treatment for sea lice and one product within Benchmark’s Animal Health portfolio. The product is used throughout the global salmon industry for the control of pre-adult to adult stages of sea lice. Used by Benchmark customers throughout the UK, it is well recognised as a reliable, gentle and effective treatment option.
The agreement, which took effect from 28th March, will increase the technical support available for UK customers, providing them with additional resources with both Benchmark and STIM on hand to support their effective sea lice management. STIM Scotland Ltd are professional distributors with a well-established and trusted network of delivery, which will ensure customers can access secure and consistent supply.
Announcing the agreement, John Marshall, Head of Benchmark Animal Health, says, “At Benchmark, we are committed to helping customers manage the ongoing challenge of sea lice. Our exclusive agreement with STIM Scotland offers us the opportunity to further support our customers in their use of Salmosan® Vet. I am confident this will have a positive impact on our customer’s operations”.
Campbell Morrison, Key Account Manager at STIM Scotland Ltd, adds, “In the UK, as well as in Norway and Chile, STIM strives to supply a complete range of the most important fish health products available. Salmosan® Vet is certainly one of those and we are pleased to add the product to our growing product catalogue.”
Managing sea lice carries an annual cost of approximately £40m in Scotland alone each year and is considered to be the greatest biological challenge to the growth of the aquaculture industry.
Benchmark Animal Health is the Marketing Authorisation holder for Salmosan® Vet in the UK and will remain so after the agreement. Since 2009, Benchmark has been supporting farmers across the globe in controlling sea lice through this treatment.
For more information about Benchmark visit the website, HERE.
The Aquaculturists
No comments:
Post a Comment